Showing results (181-190 of 246) with videos related to
Sort By:
Pageof 25
Journal of the American College of Surgeons|January 16, 2017
Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional StudyGregory C Wilson, Shishir K Maithel, David Bentrem, et al.Annals of Surgical Oncology|July 28, 2016
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First ApproachBrent T Xia, David A Habib, Vikrom K Dhar, et al.Annals of Surgical Oncology|May 5, 2022
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic ConsortiumKristin N Kelly, Francisco I Macedo, Max Seaton, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 12, 2017
Fistulojejunostomy Versus Distal Pancreatectomy for the Management of the Disconnected Pancreas Remnant Following Necrotizing PancreatitisVikrom K Dhar, Jeffrey M Sutton, Brent T Xia, et al.The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 6, 2024
Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505Davendra P S Sohal, Robert D Boutin, Leon Lenchik, et al.International Journal of Cancer|June 12, 2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinomaDusten Unruh, Kevin Turner, Ramprasad Srinivasan, et al.Annals of Surgical Oncology|February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial designMatthew H G Katz, Robert Marsh, Joseph M Herman, et al.Cancers|December 22, 2020
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal AdenocarcinomaLoryn Holokai, Jayati Chakrabarti, Joanne Lundy, et al.Annals of Surgery|March 12, 2011
Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique?Clifford S Cho, David A Kooby, C Max Schmidt, et al.Pageof 25